Scottish Parliament votes against assisted dying bill amid concerns over pharmacist protections The bill was rejected by 69 votes to 57, after several MSPs cited concerns about the lack of safeguards for healthcare professionals who do not wish to participate in assisted dying.…
Global regulators set out principles for safe AI across the medicines lifecycle From discovery to manufacturing and post-marketing surveillance, new joint principles from the European Medicines Agency and US Food and Drug Administration are aimed to ensure that AI in medicines development is human-centred, risk-based and transparent.…
RPS opposes Scottish assisted dying bill after protections for pharmacists removed The Royal Pharmaceutical Society has expressed concern that the final draft of the Assisted Dying for Terminally Ill Adults (Scotland) Bill removes a “conscience clause”, which would protect pharmacists who choose not to participate in assisted dying.…
Health news round up: AMR, pain and genitourinary cancers A weekly summary of important developments in pharmacy and health news that you may have missed.…
National pharmacy board meetings: February 2026 A summary from the final meetings of the national pharmacy boards before the Society’s transition to become the Royal College of Pharmacy.…
Privy Council approves Royal Charter changes The Royal Pharmaceutical Society will become the Royal College of Pharmacy on 15 April 2026 following King Charles III’s approval.…
Why the UK must put medicines at the forefront of a new EU relationship Why the UK’s priorities need to change in terms of medicines regulation, which will ultimately determine whether future patients will benefit from affordable medicines supply.…
EMA proposes modifying pre-existing clinical trials during public health emergencies Draft guidance has suggested trial adaptations, including changing endpoints, introducing new patient cohorts, adding new trial arms and adapting randomisation.…
Regulators set out support for in-orbit pharmaceutical manufacturing In a joint statement, UK regulators said that the production of materials and products in space have the potential to offer higher quality medicines compared with those made on Earth.…
Government to implement changes to NICE cost-effectiveness threshold The Department of Health and Social Care “acknowledged the concerns” raised in a consultation on the changes “regarding potential political interference in NICE's work and methods”.…
